Astrana Health, Inc. (ASTH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	3.8B	3.2B	2.0B	1.4B	1.1B
Cost of Revenue	3.5B	2.9B	1.8B	1.2B	944.7M
Gross Profit	354.5M	295.8M	271.4M	215.0M	199.5M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	238.5M	217.3M	154.1M	112.6M	77.7M
General & Admin Expense	238.5M	217.3M	154.1M	112.6M	77.7M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	15.6M	—	27.9M	17.7M	17.5M
Total Operating Expenses	254.1M	217.3M	182.0M	130.3M	95.2M
Cost and Expenses	3.7B	3.1B	1.9B	1.3B	1.0B
Operating Income (EBIT)	100.5M	78.5M	89.3M	84.6M	104.3M
Non-Operating
Interest Income	17.2M	12.2M	14.5M	14.2M	2.0M
Interest Expense	67.3M	49.9M	33.1M	16.1M	7.9M
Net Interest Income	(50.1M)	(37.8M)	(18.6M)	(1.9M)	(5.9M)
Other Non-Op Income/Expense	(40.4M)	(38.9M)	(8.5M)	5.2M	(17.6M)
Non-Operating Income (excl Interest)	(27.0M)	(11.0M)	(24.6M)	(21.3M)	9.7M
EBT (Pre-Tax Income)	60.1M	39.6M	80.8M	89.8M	86.6M
Income Tax Expense	20.9M	15.5M	30.9M	32.0M	40.9M
Bottom Line
Net Income	40.5M	22.5M	43.1M	60.7M	45.2M
Earnings from Cont. Ops	39.2M	24.1M	49.9M	57.8M	45.7M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	40.5M	22.5M	43.1M	60.7M	45.2M
Per Share
Basic EPS	$0.83	$0.46	$0.91	$1.30	$1.00
Diluted EPS	$0.82	$0.46	$0.90	$1.29	$0.99
Revenue Per Share	$78.27	$64.83	$42.66	$29.69	$25.44
Shares
Basic Shares Outstanding	49.1M	49.1M	47.7M	46.7M	45.0M
Diluted Shares Outstanding	49.8M	49.4M	48.2M	47.1M	45.6M
Profitability Metrics
EBITDA	174.9M	135.3M	141.8M	123.7M	112.1M
D&A	47.5M	45.7M	27.9M	17.7M	17.5M
EBIT	127.4M	89.5M	113.9M	105.9M	94.5M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026